
A study based on a representative sample of over 10,000 US adults revealed that nearly 1 in 5 individuals with type 2 diabetes, without cardiovascular disease (CVD) symptoms, have elevated levels of high sensitivity cardiac troponin T (hs-cTnT), a marker of cardiac damage. The findings suggest that hs-cTnT could be a valuable indicator for identifying individuals with diabetes who may benefit from more aggressive CVD risk reduction strategies. The study emphasizes the significance of early detection and treatment of CVD in this high-risk population. It also highlights the need for additional non-statin therapies to lower cardiovascular risk in people with type 2 diabetes.
Like
Save
Share